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Prospective population surveillance has been conducted for candidemia in Brazil (A. L. Colombo, M. Nucci,
B. J. Park, et al., J. Clin. Microbiol. 44:2816–2823, 2006). In the present study, a total of 63 isolates from 61
patients, representing 11 medical centers from nine geographic regions, were characterized by multilocus
sequence typing (MLST). A total of 48 unique profiles or diploid sequence types (DSTs) were observed, with
nine new sequence types (STs) and 32 new DSTs. There were no apparent correlations between center/region
and DST patterns. Subtypes were compared to those in a known characterized reference set, including a large
database of strains obtained worldwide. Significantly, only one C. albicans group 2 isolate was found in our
collection, although isolates from this particular group are commonly found worldwide. These data, combined
with information from other previously reported studies, establish a statistically significant diminishment of
group 2 strains in Central and South America, including Mexico and portions of the Southwestern United
States.
The commensal yeast Candida albicans is a normal part of
the human microflora. This species can be an agent of mucosal
infections of healthy individuals and is capable of causing in-
vasive disease, particularly when the host is debilitated or im-
munocompromised. Bloodstream infections due to Candida
albicans are associated with significant morbidity and mortality
(21), and its importance has resulted in the initiation of senti-
nel and population-based surveillance studies to determine the
burden of disease and the incidence of antifungal resistance (9,
30, 32). Many corollary genetic analyses of C. albicans have
also been undertaken (1, 10, 25), and our understanding of
virulence and pathogenicity in this species has increased (21).
C. albicans is diploid, with a primarily clonal mode of repro-
duction. However, there is evidence for a low level of recom-
bination between strains, and either cryptic or parasexual mei-
osis has been suggested (24). Within a single strain there can
be relatively high rates of nonhomologous mitotic recombina-
tion, translocation, and aneuploidy (24). These are thought to
be the major underlying mechanisms responsible for the ob-
served genetic diversity within the species (1, 24, 25).
Early cladistic studies by a variety of workers (16, 22) dem-
onstrated three major groups, or clades, of strains within the
species. Those studies used collections that were primarily
from Northern Europe and the United States. More-recent
studies using a variety of DNA markers have substantiated and
extended these results (11). In particular, the use of the mid-
dle-repetitive element Ca3 demonstrated this tripartite popu-
lation structure (23), and the groups were named groups 1 to
3. Group 1 strains are typically the majority of any defined
population (15, 22, 23). Unlike groups 2 and 3, this group is
positively correlated with the presence of a subtelomeric ele-
ment (8).
Later analyses extended the number of strains to larger
geographic regions, and it was observed that other clades were
associated (but not exclusively) with Europe (termed group
“E”) and South Africa (termed group “SA”) (2, 23, 26). To
date, it has been assumed that groups 1 to 3 are ubiquitous and
distributed worldwide, although the number of analyzed iso-
lates from many discrete geographical regions has been too low
to give statistical support for this concept.
More recently, multilocus sequence typing (MLST) has been
developed for Candida albicans, using seven consensus “house-
keeping” genes (3, 4, 19, 29). For each locus individually,
alleles are assigned on the basis of single-nucleotide polymor-
phisms (SNPs) found within the sequenced region. Because C.
albicans is diploid, there are three possibilities for each poly-
morphism: two homozygous and one heterozygous. By defini-
tion, a single base change defines a new allele, or sequence
type (ST) (4, 18). The summation of each sequence type for the
seven loci then collectively defines a diploid sequence type
(DST) for a given strain. To date, there are between 100 and
200 known alleles for each locus and between 1,000 and 2,000
DSTs (17). In a recent study, Odds et al. used MLST in a
cladistic analysis of 1,391 strains from a worldwide collection.
Groups 1, 2, and 3 were again observed, along with group SA
(termed group 4 in this study) (17). Clade E was divided into
clade SA and a new clade (group 11), which contained 7.5% of
the total isolates, and 96.7% of the total isolates could be
assigned to one of 17 groups (17). The five largest clades
assigned by MLST as groups 1 to 4 and 11 corresponded with
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up to 70% of C. albicans isolates found worldwide (19, 28, 29).
In addition, Odds et al. scored strains for the presence of the
IS1 element as a corollary to MLST typing. Termed “ABC”
typing, this simply refers to the presence, “A,” absence, “B,” or
heterozygosity, “C,” of the element.
Although there have been several studies attempting to re-
late differences in geographic locations and virulences among
C. albicans strains, clinical and pathogenic differences among
isolates of different clades are still unclear (17). The present
study was undertaken to determine the MLST groups and
ABC types of bloodstream isolates from Brazil and to deter-
mine if there was a correlation between genotypes and geo-
graphic origins of the surveillance population.
MATERIALS AND METHODS
C. albicans isolates. We evaluated C. albicans bloodstream isolates recovered
from 61 randomly chosen patients with candidemia collected during a multi-
center surveillance study of 11 public tertiary care hospitals, representative of the
public health system of nine major cities in Brazil (5). These hospitals are located
in the South, Southeast, and Central regions, including the metropolitan areas of
Rio de Janeiro and Sa˜o Paulo (5). Each isolate was obtained from a different
patient, with the exception of three distinct strains isolated from one patient
during the course of candidemia (5). These three strains were included in the
study, for a total of 63 isolates.
Species identification. Isolates were identified according to their microscopic
morphologies on cornmeal Tween 80 agar and by biochemical tests using the ID
32C system (bioMe´rieux AS, Marcy l’Etoile, France).
MLST and ABC typing. The methodology of MLST was described in detail
previously (4, 18). Briefly, DNA was prepared from fresh cultures grown on
Sabouraud dextrose agar using a MoBio (Carlsbad, CA) microbial DNA isola-
tion kit according to the manufacturer’s instructions. PCR primers and condi-
tions were described previously in reference 4. PCR fragments were visually
inspected by electrophoresis on 2% agarose prior to purification by Exosap-It
treatment (USB, Cleveland, OH). Fragments were sequenced in both forward
and reverse orientations using the original PCR primers. Sequencing was per-
formed by using ABI (Carlsbad, CA) reagents and equipment according to the
manufacturer’s recommendations. DNA analysis was performed by using Se-
quencher software (Genecodes, Ann Arbor, MI), and each electrophoretic trace
was visually examined for heterozygosities. The seven gene loci AAT1a, ADP1,
ACC1, MPIb, SYA1, VPS13, and ZWF1b were assigned from the MLST Candida
albicans database (http://calbicans.mlst.net) as sequence types (STs), defining
unique sequences for pairs of alleles, and diploid strain types (DSTs), which
defined unique combinations of genotypes. By definition, any nucleotide differ-
ence within the defined region of a locus is scored as a new ST and will also be
scored as a new DST. Single-nucleotide polymorphisms (SNPs) from the diploid
sequence were converted as a single sequence and concatenated as previously
defined (18). Cladistic analysis was performed with Mega software, version 4
(28), and Phylip, version 4.0 (7). ABC typing, based on the presence or absence
of an intron in the 26S ribosomal DNA (rDNA) region, was determined for all
isolates as described previously by Lott et al. (14), using the same DNA as that
used for MLST. Primers and PCR conditions were previously described (14).
Fragments were electrophoresed on 2% agarose with ethidium bromide and
visually scored for the presence, absence, or heterozygosity of the insertion
element.
Definition of clades. To delineate clusters of closely related strains, we applied
the same unweighted p-distance cutoff value used previously by Odds et al. (17).
The cutoff of 0.1 used for C. albicans in that study was chosen because it
separated groups 2 and 4, which were well discriminated by other typing methods
(22). eBURST analysis (http://eburst.mlst.net/v3/enter_data/single/) was per-
formed under the criterion of strict clonality (6).
RESULTS
A total of 63 isolates from 61 patients were included in this
study. For most patients, a single colony was observed and chosen
from the primary culture plate. Multiple isolates were obtained
from several patients, but subsequent analysis showed that the
isolates were of the same MLST and ABC types. In these cases,
a single representative isolate was included for the patient. There
was no known epidemiological relationship among the patients.
Isolates originally identified as C. albicans by standard meth-
ods underwent molecular subtyping by using MLST and ABC
typing. DNA sequencing of 373- to 491-bp fragments from the
coding region of each of the genes AAT1a, ADP1, ACC1,
MPIb, SYA1, VPS13, and ZWF1b resulted in a data set of 2,883
nucleotides for each isolate. The seven genes sequenced for
the 63 C. albicans strains exhibited a total of 73 variable sites,
representing 2.6% of total sites. A total of 48 unique profiles or
diploid sequence types (DSTs) were observed, with 9 new
sequence types (STs) and 32 DSTs. New STs were found in the
AAT1 (two new sequence types) ACC1 (one), ADP1 (one),
VPS13 (one), and ZWF1 (four) loci. No new STs were ob-
served for the MPIb and SYA loci. For eight of the nine new
STs, new combinations of previously described nucleotide
polymorphisms were observed. For AAT1 ST109, there was a
new mutation in addition to a new combination of known
polymorphisms. This was a G3A second-position nonsynony-
mous transition, Gly3Asp, at position 299 relative to the ref-
erence start position (4). The remaining 23 new DSTs were a
result of new combinations of existing STs. New STs and DSTs
are shown in Table 1.
For previously described diploid sequence types, DST69 was
the most common DST isolated. DST69 was found in isolates
from 10 patients (16.5%) in six medical centers from six dif-
ferent cities: Brasília (three strains), Curitiba (two strains),
Federal University of Rio de Janeiro (UFRJ) in Rio de Janeiro
(two strains), Ribeira˜o Preto (one strain), Sa˜o Jose´ do Rio
Preto (one strain), and Hospital do Servidor Pu´blico Estadual
(HSPE) in Sa˜o Paulo (one strain). DST24 was the second most
isolated DST and was found in isolates from four patients
(6.5%): two in Brasília, one in Campinas, and one at HSPE in
Sa˜o Paulo. Isolates from three other patients had DSTs that
were represented twice in the population.
Polymorphisms for all seven loci were concatenated and
used for both distance matrix and parsimony-based approaches
in a cladistic analysis. In both cases, the general topologies of
the derived dendrograms were similar but not identical. Both
parsimony and neighbor-joining (including the unweighted-
pair group method using average linkages [UPGMA]) algo-
rithms clustered most group 1 isolates together. A representa-
tive dendrogram based on UPGMA for the 63 total strains is
given in Fig. 1. For group assignments, similar matrices that
included reference sequences from the 17 previously described
groups were constructed. We observed that by using a previ-
ously defined P value cutoff of 0.1 (18), all but one isolate could
be assigned (isolate designated a “singleton”). This P value
cutoff could discriminate the two strains assigned to groups 2
and 4 (Fig. 1). Thirty-five of the 63 isolates (55%) were found
to be group 1 isolates. Groups 8 and 3 were the next most
abundant, each containing approximately 13% of the popula-
tion. We observed that 50 isolates (82%) were of ABC type A,
while types B and C were found for 16.5% and 1.5% of the
isolates, respectively. A large percentage of group 1 isolates
were of type A, consistent with previous suggestions that these
isolates were related by descent (Fig. 2) (11).
For group 1 isolates, we were interested in determining
whether relationships of clonal descent could be inferred.
An eBURST analysis was performed by using all group 1
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isolates from this study and several previously reported
strains that had DSTs unique to Brazil (http://test1.mlst.net
/earth/maps/). These results are shown in Fig. 2. We had
initially observed that several of the DSTs observed in this
study appeared to be similar. For example, DST1167 and
DST1181 differ only by a ZWF1 ST. A closer examination
revealed that this could be explained by a loss-of-heterozy-
gosity (LOH) event in DST1181. Likewise, DST1164 and
DST1165 share a unique ZWF1 ST, and their difference can
be explained by an LOH in the MP1b locus. We also found
examples where previously reported DSTs were related to
unique DSTs from this study. As shown in Fig. 2, the anal-
ysis of clonal relatedness demonstrated that 17 of the 25
unique profiles clustered into one clonal cluster. DST1167
and DST1181 were not included. However, as expected,
DST1164 and DST1165 were included, as were Brazilian
DSTs 1373 and 1400 from a previous study. DST69 was
calculated to be the progenitor of the cluster.
DISCUSSION
Comparatively few prospective studies of candidemia have
been conducted in Brazil, and the corresponding collection of
bloodstream isolates presented here can be studied from a
population perspective. First, we observed that one-third (22/
63) of the strains could be classified as group 1 strains. This was
not unexpected, in that group 1 strains have been shown to be
a significant percentage of all worldwide geographic commu-
nities (15, 20). Second, we observed that slightly over half
(33/63) of the strains represented new DSTs and that a major-
ity of these were derived from new combinations of existing
STs. Again, we do not believe that this is unexpected. Under
the assumption that STs behave as alleles in the population
(i.e., freely associating), then if C. albicans is undergoing any
recombination, there will be a significant reshuffling of alleles,
and corresponding new DSTs will be formed. We have ob-
served that for group 1 strains, some newly described DSTs
appear to be related. For example, DST1164 and DST1165
share unique ZWF1 STs (Table 1), and the difference in their
genotypes can be explained by an LOH in the MP1b locus. We
also observed that some new group 1 DSTs appear to be
related to previously described DSTs unique to Brazil (Fig. 2).
Interestingly, DST69 was selected to be the progenitor of the
clonal cluster. This DST is the most common genotype found
in group 1 isolates and is the most commonly found DST
worldwide (17). We believe that this lends additional support





AAT1 ACC1 ADP1 MPIb SYA VPS13 ZWF1
1 54 31 10 36 66 185 111 1162 B 16
2 55 14 4 54 6 6 15 1171 A 8
3 13 13 85 6 50 32 15 1163 B 3
4 20 3 6 2 51 36 5 1172 A 1
5 2 5 5 12 2 6 154 1164 A 1
6 25 7 6 3 34 24 37 1173 A 8
7 70 14 6 4 35 10 8 1174 B 4
8 2 8 2 2 2 6 5 1175 A 1
9 42 5 5 19 2 6 5 1176 A 1
10 2 5 5 2 2 6 154 1165 A 1
11 13 10 15 2 2 37 15 1177 B 3
12 33 14 38 2 78 122 5 1178 B 8
13 2 2 6 2 2 6 5 1179 A 1
14 108 5 5 2 2 6 5 1166 A 1
15 60 3 3 3 3 39 95 1180 A 9
16 47 14 57 28 44 30 136 1167 A 17
17 47 14 57 28 44 30 5 1181 A 17
18 60 3 3 3 3 39 3 1182 A 9
19 2 5 2 4 2 24 5 1183 A 1
20 109 7 10 4 65 110 155 1168 A S
21 2 5 5 27 2 71 5 1184 A 1
22 2 2 5 4 2 6 5 1185 A 1
23 13 7 15 6 77 55 156 1169 B 3
24 35 2 4 4 36 4 4 1186 A 2
25 2 7 6 3 6 27 37 1187 A 8
26 21 17 21 19 27 27 22 1188 B 12
27 31 5 6 2 2 6 5 1189 C 1
28 13 74 15 6 7 37 5 1176 A 3
29 47 14 52 28 44 30 6 1190 A 17
30 8 5 2 2 2 24 5 1191 A 1
31 13 11 15 15 50 37 15 1192 A 3
32 47 3 52 28 44 4 6 1193 A 17
a Numbers refer to assigned alleles (STs) (http://calbicans.mlst.net/). Boldface type indicates new STs from existing SNPs. Italic type indicates a new mutation.
b Numbers refer to assigned DSTs.
c S, singleton.
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to the concept that many Brazilian group 1 strains are derived
from a common ancestral type.
Perhaps the most interesting aspect of the present study is
the distribution of strains within groups. Groups 5 to 17 are
considered minor components of the population hierarchy and
are found in various degrees in different geographic popula-
tions (15, 20). However, in populations from North America,
Europe, and Asia, groups 1 to 4 comprise the large majority of
the population (up to 80%) (15). In particular, group 2 strains
comprise approximately 20% of the worldwide collection, and
there is evidence that they are even more prevalent in Western
Europe (17, 20). This clade is present in Japan and additional
worldwide locations, including the northern United States
(27). In the present study, only one group 2 strain was identi-
fied. This strain was obtained from a patient with persistent
candidemia and no known travel history outside South Amer-
ica (5). Presently, there are 100 isolates in the database (http:
//calbicans.mlst.net.) from South America, Central America,
and Mexico, and of these, there has been only one other group
2 isolate described (from Chile). Using a chi-square statistic
and an average probability of 20%, the derived 2 value was
18.5, with a P value of 0.0001, showing that the South Amer-
ican frequency matches the worldwide frequency. Using a
more conservative Fisher’s exact test, the P value was 1.6 
105 (two tailed), and this would be in the expected range.
However, when the results of this study are added to the
database, the combined probability (chi square) is now a 2
value of 35, and with the Fisher’s exact test, the P value was
1.5  108, showing that the South American frequency
matches the worldwide frequency. Thus, there is now very
strong evidence that a geographic abatement exists for group 2
in this region of the world.
FIG. 1. UPGMA dendrogram showing uncorrected p distances for 63
Candida albicans strains typed by MLST. The dashed line shows the cutoff
at a P value of 0.1, used to delineate clades. Bootstrap values are shown
at the nodes (n 1,000). Clade (group) assignments are given at the right.
FIG. 2. eBURST analysis of group 1 strains from this study and
previously observed DSTs unique to Brazil. The blue circle (DST69)
represents the predicted progenitor of the clonal cluster, and yellow
circles represent secondary progenitors. Sizes are proportional to the
frequency in the population. Green numbers represent DSTs reported
in a previous study (17).
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Some earlier studies might shed light on how far north this
abatement might extend. Pujol and coworkers examined pop-
ulations from the United States using the repetitive element
Ca3 and observed that no group 2 strains were found in a
collection of 29 isolates in Texas, including Dallas and
Galveston (23). However, other studies involving microsatellite
allelic frequencies (13) suggested that group 2 strains are
present in northern California. We therefore hypothesize that
the abatement zone may extend through the Southwestern
United States. This suggests some form of selection, and the
boundary may imply a climate zone. This seems improbable,
however, considering the known epidemiology of the organ-
ism. C. albicans is not known to exist in the environment for
long periods, only transiently during person-to-person trans-
mission. Perhaps a better explanation may be that there is
some host factor that is prevalent in the population and leads
to a diminishment of a strain type. These factors could possibly
include specific HLA types or Toll-like receptor alleles. Unlike
group 1 strains that contain group-specific genetic elements
and where there has been a suggestion that these may repre-
sent more successful colonizers (8, 33), relatively little is known
about group 2 strains. There is genetic evidence that C. albi-
cans strain groups have been separated by several million years
(12).
Phenotypic differences among C. albicans clades have been
described previously (15). The most evident example concerns
the resistance to flucytosine, where it is confined to group 1
isolates. In our study, the seven isolates showing flucytosine
MICs of 4 g/ml were classified as clade 1 type A (data not
shown). Also, resistance to terbinafine has been found to be
related to isolates in clade 1 and, to a lesser extent, isolates in
clade 3 (17). Previously reported studies also described a
higher proportion of salt-tolerant isolates in clade 1, very low
whole-cell acid phosphatase activity among C. albicans clade 2
strains, and statistically significant interclade differences in
numbers of midrepeat sequences in some members of the ALS
and HYR gene families, which encode cell surface proteins
(17).
Finally, the isolations of C. albicans strains recovered from
human patients and animals do not seem to follow the same
pattern, as demonstrated in two studies where the distributions
of clades recovered from both groups were significantly differ-
ent (19). Future studies may help resolve questions pertaining
to the evolution of strain groups in this human-commensal
species as well as help address the issues surrounding the
source(s) of infection (colonization), virulence, and geographic
location.
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